Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a simple painkiller speed up childbirth?

NCT ID NCT07394491

Symptom relief Sponsor: Federal Teaching Hospital Abakaliki Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether giving paracetamol through a vein or tramadol as a shot can shorten the time women spend in labor. 189 women in active labor were randomly assigned to one of the two medicines. The goal was to see if either drug reduces the length of the first, second, and third stages of labor.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

189 people

The number who actually took part.

Started

Nov 2022

Finished

Feb 2023

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

16 to 40 years

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Spontaneous active phase labour * No contraindication to vaginal delivery Exclusion Criteria: * Clinical evidence of cephalopelvic disproportion * Malpresentation, * Multiple pregnancy, * Previously scarred uterus, * Preterm labour, * Induced labour * Antepartum hemorrhage. * History of known allergy to tramadol and paracetamol or opioids or * History of narcotics dependency. * History of renal disease, * Fetal distress * Intrauterine fetal death.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Labour duration are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Labour duration

Contacts and locations

Locations

  • Assumpta Nnenna Nweke

    Abakaliki, Ebonyi State, 480, Nigeria

More trials for these conditions

Other studies related to the condition(s) this trial covers.